DSGN Design Therapeutics, Inc.
Healthcare$11.40+3.92%ClosedMarket Cap: $712.0M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$17.50
Target (Median)
$17.50
Target Range
$14.00 - $21.00
Upside from current price: 53.5%
Rating Distribution
2 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-04 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-03-10 | RBC Capital | maintain | Outperform | Outperform |
| 2025-12-03 | Leerink Partners | upgrade | Outperform | Market Perform |
| 2025-11-20 | RBC Capital | upgrade | Outperform | Sector Perform |
| 2025-11-06 | RBC Capital | maintain | Sector Perform | Sector Perform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.64 | $204.8M | 5 |
| Sun Dec 31 | $-1.95 | $8.4M | 5 |
| Mon Dec 31 | $-1.51 | $72.1M | 1 |
| Tue Dec 31 | $-0.05 | $235.6M | 1 |